USD 3.1 billion
Report ID:
SQMIG35H2172 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
124
|Figures:
77
Protein Engineering Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.64 billion in 2024 to USD 13.13 billion by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).
Rapidly increasing demand for biopharmaceuticals and growing investments in the development of new genetic engineering technologies are projected to benefit protein engineering market growth. High investments in medical R&D to develop new vaccines and biologics for the treatment of surging chronic diseases are also expected to create new opportunities for protein engineering providers over the coming years. Advancements in synthetic biology and increasing investments in the development of advanced protein engineering technologies and techniques are also forecasted to create new business opportunities for protein engineering companies in the future.
High demand for personalized medicine and targeted therapies around the world is also estimated to promote the sales of protein engineering products and services in the future. An upsurge in the incidence of multiple chronic and infectious diseases is also estimated to boost the demand for protein engineering in the long run. However, intellectual property issues and disputes, challenges in maintaining protein stability, and ethical concerns regarding protein engineering are key constraints that could slow down market development going forward.
Market snapshot - 2025-2032
Global Market Size
USD 3.1 billion
Largest Segment
Instruments
Fastest Growth
Reagents
Growth Rate
17.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Protein Engineering Market is segmented by Product, Technology, Protein Type, End Use and region. Based on Product, the market is segmented into Instruments, Reagents and Software & Services. Based on Technology, the market is segmented into Rational Protein Design, Directed Evolution, Hybrid Approach, De Novo Protein Design and Others. Based on Protein Type, the market is segmented into Insulin, Monoclonal Antibodies, Vaccines, Growth Factors, Colony Stimulating Factors, Coagulation Factors, Interferon and Others. Based on End Use, the market is segmented into Academic Research Institutes, Contract Research Organizations (CROs) and Pharmaceutical & biotechnology companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Protein Engineering Market Analysis by Protein Type
Monoclonal antibodies are projected to spearhead the global demand for protein engineering in the future. Growing investments in the research and development of novel monoclonal antibodies and their rising use in the development of novel therapeutics and therapies are projected to help this segment maintain its high market share. The rising use of targeted monoclonal antibodies for the treatment of chronic diseases such as cancer will also create new opportunities for protein engineering companies in the future. A combination of next generation gene technologies and protein engineering technologies are being used to create innovative new monoclonal antibodies.
Meanwhile, the use of protein engineering for insulin is projected to increase at a rapid pace across the study period and beyond. Rapidly surging diabetic population around the world and high demand for insulin are slated to help this segment become the most opportune one in the market. Growing investments in the development of novel insulin products around the world are also expected to create new business scope for protein engineering providers going forward. Use of protein engineering for development of new types of insulin, which is more effective in diabetes management will also bolster protein engineering market development in the long run.
Instruments are forecasted to account for a major chunk of the global protein engineering market share and bring in about half of the global market revenue as well. High investments in the development and launch of new protein engineering instruments to keep up with advanced medical technologies will also help this segment maintain its dominance through 2031. Real-time PCR apparatus and chromatographic systems are some of the key protein engineering instruments and products that are projected to be highly popular among end users going forward. Integration of advanced technologies such as artificial intelligence and machine learning can help in the creation of automated protein engineering instruments and tools.
On the other hand, the demand for protein engineering reagents is estimated to rise at a robust pace over the coming years. The growing application scope of protein engineering reagents in multiple applications ranging from monoclonal antibodies to targeted therapeutics is slated to create a new business scope for protein engineering companies in the future. The COVID-19 pandemic gave a significant boost to the sales of protein engineering reagents as they are crucial in the development of novel vaccines. High investments in protein research are also expected to promote healthy market growth via this segment.
To get detailed analysis on other segments, Request For Free Sample Report
High investments in medical R&D and presence of a developed healthcare infrastructure help North America to maintain a top spot in the global protein engineering market. Rising demand for personalized medicine and advancements in protein engineering technologies are also helping create new business scope in this region. Canada and the United States are forecasted to be the leading revenue generators for protein engineering providers operating in this region. High investments in medical R&D by governments in this region will also promote the demand for protein engineering going forward. Moreover, the presence of top pharmaceutical and biotechnology companies in this region will also help the dominance in the long run.
Meanwhile, the demand for protein engineering in the Asia Pacific region is slated to increase at a robust pace across the study period and beyond. Growing investments in healthcare infrastructure development, rising prevalence of chronic disorders, and growing demand for advanced healthcare technologies and products are slated to create new opportunities for protein engineering providers in Asia Pacific. India, China, and Japan will be the most rewarding markets for protein engineering companies operating in this region. Growing diabetic population and rising geriatric population will also create new business scope for protein engineering market players in the long run.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Demand for Personalized Medicine
High Investments in Synthetic Biology Research
Protein Stability Issues
Ethical Concerns
Request Free Customization of this report to help us to meet your business objectives.
Protein engineering providers should focus on increasing awareness regarding their offerings and their benefits to maximize their business scope. Collaborations will also play a vital role in helping companies expand their business across the world. Focusing on personalized medicine and biopharmaceutical production will pay off big time for all protein engineering companies in the future. Increasing the affordability of protein engineering products will also be a key trend for protein engineering providers to focus on going forward.
Top Player's Industry Profiles in Global Protein Engineering Companies
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, growing demand for personalized medicine and rising investments in synthetic biology research are projected to drive up the demand for protein engineering going forward. However, issues in maintaining protein stability and ethical concerns regarding protein engineering are slated to impede market development. High investments in medical R&D and supportive government funding allow North America to lead the global protein engineering demand outlook. Focusing on De Novo protein design could help protein engineering companies stand out from their competition and allows them to gain a competitive advantage over others as well.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 3.1 billion |
Market size value in 2032 | USD 13.13 billion |
Growth Rate | 17.4% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Protein Engineering Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Protein Engineering Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Protein Engineering Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Protein Engineering Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Protein Engineering Market size was valued at USD 2.52 Billion in 2023 and is poised to grow from USD 2.94 Billion in 2024 to USD 10.03 Billion by 2032, growing at a CAGR of 16.60% during the forecast period (2025-2032).
Protein engineering providers should focus on increasing awareness regarding their offerings and their benefits to maximize their business scope. Collaborations will also play a vital role in helping companies expand their business across the world. Focusing on personalized medicine and biopharmaceutical production will pay off big time for all protein engineering companies in the future. Increasing the affordability of protein engineering products will also be a key trend for protein engineering providers to focus on going forward. 'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'Agilent Technologies, Inc.', 'Genscript Biotech Corporation', 'Codexis, Inc.', 'Danaher Corporation', 'Bio-Rad Laboratories, Inc.', 'Bruker Corporation', 'PerkinElmer, Inc.', 'Creative Biomart', 'Abcam plc', 'Enzyme by Design Ltd.', 'Twist Bioscience Corporation', 'Cyrus Biotechnology, Inc.', 'Integrated DNA Technologies, Inc. (IDT)', 'New England Biolabs', 'Genentech, Inc.', 'Promega Corporation', 'Sutro Biopharma, Inc.'
Personalized medicine has been growing in popularity around the world as people look for more effective treatments for their conditions. Increasing specificity of disease impact based on genetics has led to high use of personalized medicine and protein engineering plays a crucial role in the development of the same. This is why the growing popularity of personalized medicine will also help protein engineering companies expand their business.
Protein engineering companies can explore the use of directed evolution to mimic natural selection in laboratories thereby creating new products that are not entirely synthetic in nature. This approach can also help researchers create more variants of protein that can be used in multiple applications to enhance the scope of treatment of chronic diseases.
High investments in medical R&D and presence of a developed healthcare infrastructure help North America to maintain a top spot in the global protein engineering market. Rising demand for personalized medicine and advancements in protein engineering technologies are also helping create new business scope in this region. Canada and the United States are forecasted to be the leading revenue generators for protein engineering providers operating in this region. High investments in medical R&D by governments in this region will also promote the demand for protein engineering going forward. Moreover, the presence of top pharmaceutical and biotechnology companies in this region will also help the dominance in the long run.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35H2172
sales@skyquestt.com
USA +1 351-333-4748